Amoéba
Develops natural microbiological solutions to manage bacterial and fungal risks.
ALMIB | PA
Overview
Corporate Details
- ISIN(s):
- FR0011051598 (+2 more)
- LEI:
- 9695005QNE7C8Z0LXU64
- Country:
- France
- Address:
- 38 AVENUE DES FRERES MONTGOLFIER, 69680 CHASSIEU
- Website:
- https://amoeba-nature.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Amoéba is a biotechnology company that develops natural microbiological solutions for managing bacterial and fungal risks. The company's core technology is based on the patented use of the amoeba *Willaertia magna* C2c Maky and its biocidal properties. Its primary focus is on agricultural biocontrol, offering a biofungicide derived from a mechanically lysed amoeba. This product targets plant diseases such as mildews, rusts, and powdery mildew, providing a biological alternative to chemical treatments. Amoéba has also developed applications for its technology in the treatment of bacterial risk in industrial water systems, on surfaces, and for chronic wounds.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2023-02-16 17:45 |
AMOEBA dépose une demande de permis de construire pour son usine 100% biocontrô…
|
French | PDF • 3.2 MB | ||
| 2023-02-15 08:30 |
AMOEBA signe un nouveau contrat de financement de 9 millions d’euros sous forme…
|
French | PDF • 315.0 KB | ||
| 2023-02-15 08:30 |
AMOEBA signs a new €9 million simple bond financing agreement with Nice & Green
|
English | PDF • 284.8 KB | ||
| 2023-02-06 17:45 |
AMOEBA : Déclaration du nombre de droits de vote et d’actions
|
French | PDF • 206.2 KB | ||
| 2023-01-27 17:45 |
AMOEBA: Cancellation of the issue of the 8th optional tranche of OCAs and signa…
|
English | PDF • 252.1 KB | ||
| 2023-01-27 17:45 |
AMOEBA : Annulation de l’émission de la 8° tranche optionnelle d’OCA et signatu…
|
French | PDF • 266.2 KB | ||
| 2023-01-10 17:45 |
AMOEBA confirme son éligibilité au dispositif PEA-PME
|
French | PDF • 256.8 KB | ||
| 2023-01-05 17:45 |
AMOEBA : Déclaration du nombre de droits de vote et d'actions
|
French | PDF • 205.2 KB | ||
| 2023-01-03 17:45 |
AMOEBA : Bilan semestriel du contrat de liquidité
|
French | PDF • 405.1 KB | ||
| 2022-12-20 17:45 |
AMOEBA : US EPA approves Amoeba's biocide for use in closed cooling systems
|
English | PDF • 251.4 KB | ||
| 2022-12-20 17:45 |
AMOEBA : L'US EPA approuve le biocide d’Amoéba pour un usage dans les systèmes …
|
French | PDF • 267.4 KB | ||
| 2022-12-14 17:45 |
AMOEBA announces the issuance of the seventh tranche of 40 bonds convertible in…
|
English | PDF • 272.3 KB | ||
| 2022-12-14 17:45 |
AMOEBA annonce l’émission de la septième tranche de 40 obligations convertibles…
|
French | PDF • 362.9 KB | ||
| 2022-12-05 17:45 |
AMOEBA : Déclaration du nombre de droits de vote et d'actions
|
French | PDF • 195.1 KB | ||
| 2022-11-03 17:45 |
AMOEBA : Déclaration du nombre de droits de vote et d'actions
|
French | PDF • 222.6 KB |
Automate Your Workflow. Get a real-time feed of all Amoéba filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Amoéba
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Amoéba via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-30 | N/A | Other | Buy | 6,300 | 3,609.90 EUR |
| 2024-08-29 | N/A | Other | Sell | 5,500 | 3,564.00 EUR |
| 2024-08-28 | N/A | Other | Buy | 3,200 | 1,782.08 EUR |
| 2024-08-27 | N/A | Other | Buy | 20,049 | 11,231.45 EUR |
| 2024-08-26 | N/A | Other | Buy | 31,107 | 17,441.69 EUR |
| 2024-08-22 | N/A | Other | Buy | 2,255 | 1,298.88 EUR |
| 2024-08-20 | N/A | Other | Buy | 16,664 | 8,838.59 EUR |
| 2024-08-19 | N/A | Other | Buy | 13,390 | 6,795.43 EUR |
| 2024-08-16 | N/A | Other | Buy | 6,745 | 3,468.28 EUR |
| 2024-08-09 | N/A | Other | Buy | 40,748 | 21,559.77 EUR |
Peer Companies
